Free Trial

Chevy Chase Trust Holdings LLC Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background
Remove Ads

Chevy Chase Trust Holdings LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 388,444 shares of the medical equipment provider's stock after selling 13,735 shares during the quarter. Intuitive Surgical makes up about 0.6% of Chevy Chase Trust Holdings LLC's holdings, making the stock its 23rd biggest holding. Chevy Chase Trust Holdings LLC owned about 0.11% of Intuitive Surgical worth $202,752,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in ISRG. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. 83.64% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

A number of equities research analysts have weighed in on ISRG shares. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Truist Financial increased their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Finally, CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $613.10.

View Our Latest Report on Intuitive Surgical

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last quarter. Insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG traded up $4.16 on Monday, reaching $595.55. 1,188,781 shares of the company's stock traded hands, compared to its average volume of 1,979,754. The firm has a market cap of $212.12 billion, a PE ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. The stock has a 50-day simple moving average of $559.48 and a 200-day simple moving average of $520.19. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Archer Aviation: Sinking Now, Soaring Soon?

Archer Aviation: Sinking Now, Soaring Soon?

MarketBeat analyst Gabriel Osario-Mazilli breaks down what’s next for Archer and how investors should play this move.

Recent Videos

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads